Varma Mutual Pension Insurance Co acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 17,563 shares of the company’s stock, valued at approximately $6,848,000.
Several other institutional investors have also recently added to or reduced their stakes in the business. Sumitomo Life Insurance Co. boosted its holdings in shares of HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after buying an additional 20 shares during the period. MJP Associates Inc. ADV increased its position in HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after buying an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC increased its holdings in shares of HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after acquiring an additional 21 shares during the period. Anchyra Partners LLC increased its stake in shares of HCA Healthcare by 3.7% in the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after purchasing an additional 21 shares during the period. Finally, Plato Investment Management Ltd grew its holdings in HCA Healthcare by 0.6% in the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after buying an additional 22 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.
Analyst Ratings Changes
Several research analysts have recently issued reports on HCA shares. Morgan Stanley decreased their price target on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research note on Monday, July 27th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $435.00 price objective on shares of HCA Healthcare in a report on Monday, July 27th. Cantor Fitzgerald dropped their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research report on Tuesday, July 7th. Stephens dropped their price target on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Finally, Argus cut their target price on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $462.64.
HCA Healthcare Stock Down 0.0%
HCA stock opened at $429.08 on Monday. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The company has a market cap of $92.90 billion, a price-to-earnings ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10. The company has a 50 day moving average of $397.16 and a two-hundred day moving average of $443.77.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same period last year, the company earned $6.84 earnings per share. HCA Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, research analysts anticipate that HCA Healthcare, Inc. will post 29.47 EPS for the current year.
HCA Healthcare Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
